HIV_NN
type_NN
1_CD
protease_NN
activation_NN
of_IN
NF-kappa_NN
B_NN
within_IN
T_NN
lymphoid_JJ
cells_NNS
._.

NF-kappa_NN
B_NN
is_VBZ
a_DT
nuclear_JJ
protein_NN
of_IN
the_DT
rel_NN
oncogene_NN
family_NN
capable_JJ
of_IN
enhancing_VBG
transcription_NN
of_IN
several_JJ
cellular_JJ
genes_NNS
,_,
including_VBG
IL-2_NN
and_CC
the_DT
IL-2_NN
receptor_NN
,_,
and_CC
viral_JJ
genes_NNS
transcribed_VBN
from_IN
the_DT
HIV-1_NN
LTR_NN
._.

It_PRP
has_VBZ
been_VBN
reported_VBN
that_IN
HIV-1_NN
protease_NN
may_MD
cleave_VB
the_DT
NF-kappa_NN
B_NN
precursor_NN
to_TO
its_PRP$
active_JJ
form_NN
in_FW
vitro_FW
._.

In_IN
this_DT
study_NN
the_DT
effects_NNS
of_IN
HIV_NN
protease_NN
on_IN
NF-kappa_NN
B_NN
precursor_NN
activation_NN
were_VBD
examined_VBN
in_IN
Jurkat_NN
T_NN
cells_NNS
by_IN
introducing_VBG
a_DT
protease_NN
expression_NN
vector_NN
into_IN
the_DT
cells_NNS
._.

Increased_VBN
NF-kappa_NN
B_NN
activity_NN
was_VBD
observed_VBN
and_CC
this_DT
increased_VBN
activity_NN
was_VBD
blocked_VBN
by_IN
a_DT
specific_JJ
inhibitor_NN
of_IN
the_DT
viral_JJ
protease_NN
._.

Viral_JJ
transcription_NN
,_,
as_IN
measured_VBD
using_VBG
LTR-CAT_JJ
assays_NNS
,_,
was_VBD
only_RB
slightly_RB
enhanced_VBN
in_IN
the_DT
HIV-protease_NN
expressing_VBG
cells_NNS
,_,
while_IN
secretion_NN
of_IN
IL-2_NN
and_CC
expression_NN
of_IN
the_DT
IL-2_NN
receptor_NN
were_VBD
not_RB
affected_VBN
._.

The_DT
limited_JJ
activation_NN
of_IN
NF-kappa_NN
B_NN
by_IN
HIV_NN
protease_NN
appears_VBZ
unlikely_JJ
to_TO
have_VB
a_DT
significant_JJ
effect_NN
on_IN
virus_NN
expression_NN
or_CC
T_NN
cell_NN
function_NN
._.

